Trump’s pledge to repeal and replace Obamacare already has weakened the health insurance market and likely will weaken it more. The instability will be costly, in more ways than one.
The case for academic-industry collaboration.
Teamwork image via www.shutterstock.com.
The Affordable Care Act increased the number of insured people, but skeptics have suggested the increase could be due to higher employment rates. That’s not the case, a detailed study suggests.
Cost and quality issues have long plagued the U.S. health care system because insurance companies both finance and manage medical care. So how did we get stuck with this system in the first place?
Health Insurers should be offering insurance that covers primary care, Paolucci argues.
www.shutterstock.com
As health care providers seek ways to improve care and cut costs, providers and insurance companies have teamed up. A program in Michigan where providers share notes in real time appears to work.
President Obama greets a crowd in Milwaukee in March to promote his signature health care law.
Jonathan Ernst/REUTERS
Aetna’s cutback in the ACA marketplace has raised concerns about the health of the health care law. Here’s why stories of its demise may be greatly exaggerated.
Hillary Clinton, who wants to expand access to health care insurance.
REUTERS/Chris Kaine
Picking a plan that provides the coverage you need at a price you can afford is tough. It’s even harder when you don’t have a great understanding of the language that insurers use to describe plans.
Supporters of the Affordable Care Act celebrate after the Supreme Court upheld the law in a 6-3 vote at the Supreme Court in Washington June 25 2015.
Joshua Roberts/Reuters
Choosing health insurance that provides the amount of coverage you’ll likely need at the right cost is a difficult task, especially if it’s your first time picking a plan.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Quintiles Professor of Pharmaceutical Development and Regulatory Innovation, Schaeffer Center for Health Policy and Economics, University of Southern California